0

    544673

    MDRC

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Modern Diagnostic Research C Share Price Today

    Investment Returns

    Over 1 Month -12.06% Over 3 Months -28.47% Over 6 Months -46.31% Over 1 Year 0.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Modern Diagnostic Research C fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 78.50
    • P/E Ratio (TTM) 0.00
    • Beta 1.24
    • Book Value / share 38.16
    • Return on equity 55.22%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Modern Diagnostic Research C Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 83.11
    Operating Expense 78.14
    Net Profit 5.25
    Net Profit Margin (%) 6.31
    Earnings Per Share (EPS) 3.48
    EBITDA 13.62
    Effective Tax Rate (%) 12.35
    Particulars MAR 2025 (Values in Cr)
    Revenue 77.95
    Operating Expense 66.08
    Net Profit 8.97
    Net Profit Margin (%) 11.50
    Earnings Per Share (EPS) 8.15
    EBITDA 18.82
    Effective Tax Rate (%) 29.55
    Particulars MAR 2024 (Values in Cr)
    Revenue 67.13
    Operating Expense 61.81
    Net Profit 5.79
    Net Profit Margin (%) 8.62
    Earnings Per Share (EPS) 57.95
    EBITDA 12.59
    Effective Tax Rate (%) 15.59
    Particulars MAR 2023 (Values in Cr)
    Revenue 56.28
    Operating Expense 62.55
    Net Profit -5.73
    Net Profit Margin (%) -10.18
    Earnings Per Share (EPS) -57.32
    EBITDA -0.66
    Effective Tax Rate (%) 3.53
    Particulars MAR 2022 (Values in Cr)
    Revenue 60.21
    Operating Expense 59.44
    Net Profit -1.45
    Net Profit Margin (%) -2.40
    Earnings Per Share (EPS) -14.51
    EBITDA 6.36
    Effective Tax Rate (%) 227.19
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 18.84
    ROE % 55.22
    ROCE % 36.90
    Total Debt to Total Equity 1.31
    EBITDA Margin 24.14
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 117.58
    ROE % 65.35
    ROCE % 30.15
    Total Debt to Total Equity 2.02
    EBITDA Margin 18.77
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 59.63
    ROE % -96.14
    ROCE % -19.53
    Total Debt to Total Equity 2.33
    EBITDA Margin -1.17
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.78
    Total Assets 64.57
    Total Liabilities 64.57
    Total Equity 20.72
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 13.88
    Return on Capital (%) 20.94
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.41
    Total Assets 49.48
    Total Liabilities 49.48
    Total Equity 11.75
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 11.71
    Return on Capital (%) 17.99
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.15
    Total Assets 36.54
    Total Liabilities 36.54
    Total Equity 5.96
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -15.68
    Return on Capital (%) -26.95
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.63
    Total Assets 48.69
    Total Liabilities 48.69
    Total Equity 11.69
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -2.98
    Return on Capital (%) -4.52
    Particulars MAR 2025 (Values in Cr)
    Net Income 12.72
    Cash from Operations 17.52
    Cash from Investing -13.14
    Cash from Financing -0.21
    Net change in Cash 0.37
    Free Cash Flow 30.68
    Particulars MAR 2024 (Values in Cr)
    Net Income 6.86
    Cash from Operations 6.66
    Cash from Investing -11.03
    Cash from Financing 3.36
    Net change in Cash 0.25
    Free Cash Flow 17.69
    Particulars MAR 2023 (Values in Cr)
    Net Income -5.94
    Cash from Operations -0.11
    Cash from Investing 2.10
    Cash from Financing -6.47
    Net change in Cash -4.48
    Free Cash Flow 3.21
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.13
    Cash from Operations 3.15
    Cash from Investing -5.19
    Cash from Financing 4.50
    Net change in Cash 2.94
    Free Cash Flow 8.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8834.00 64.93 13.40 127019.37 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 51.70 23.39 2.82 96.89 40.75 76.00
    SHREE PACETRONIX LTD. 135.40 16.16 2.85 50.77 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.21 0.00 2.90 24.32 1.83 5.26
    VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8834.00 84.61 12.74 127019.37 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.70 0.00 -9.65 29.66 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6015.85 26.92 4.98 6581.34 5010.00 6725.00

    Modern Diagnostic Research C shareholding pattern

    Holding
    11.63%
    72.85%
    0.03%
    15.48%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Modern Diagnostic Research C Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    52.00 1.96 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 51.70
    • 26 Days 56.90
    • 10 Days 52.60
    • 50 Days 62.50
    • 12 Days 53.00
    • 100 Days 71.60
    • 20 Days 55.20
    • 200 Days 71.60
    50.83 PIVOT
    First Support 50.15 First Resistance 51.67 Second Support 49.31 Second Resistance 52.35 Third Support 48.63 Third Resistance 53.19
    RSI 35.37 ADX 62.47 MACD -3.84 Williams % R -87.80 Commodity Channel Index (CCI) -96.29
    Date 2026-07-07 Week 5200.00 Same Day 8000.00 Month 8089.00
    1 Year 1.24 3 Year 1.26
    Over 1 Month
    -12.06% down
    Over 1 Year
    0.00% down
    Over 3 Months
    -28.47% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -46.31% down
    Over 5 Years
    0.00% down

    Modern Diagnostic Research C Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Modern Diagnostic & Research Centre Ltd?

    Answer Field

    Modern Diagnostic & Research Centre Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 52.00 as on Jul 08 2026 02:57 PM.

    What is the Market Cap of Modern Diagnostic & Research Centre Ltd Share?

    Answer Field

    The market cap of Modern Diagnostic & Research Centre Ltd for NSE ₹ 0.00 & for BSE ₹ 78.50 as on Jul 08 2026 02:57 PM.

    What is the 52 Week High and Low of Modern Diagnostic & Research Centre Ltd?

    Answer Field

    The 52 Week High and Low of Modern Diagnostic & Research Centre Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 100.00 and ₹ 49.50.

    What is 1 year return for Modern Diagnostic & Research Centre Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Modern Diagnostic & Research Centre Ltd Share?

    Answer Field

    As on Jul 08 2026 02:57 PM the price-to-earnings (PE) ratio for Modern Diagnostic & Research Centre Ltd share is 0.00.

    What is the PB ratio of Modern Diagnostic & Research Centre Ltd Share?

    Answer Field

    As on Jul 08 2026 02:57 PM, the price-to-book (PB) ratio for Modern Diagnostic & Research Centre Ltd share is 38.16.

    How to Buy Modern Diagnostic & Research Centre Ltd Share?

    Answer Field

    You can trade in Modern Diagnostic & Research Centre Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Modern Diagnostic & Research Centre Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Modern Diagnostic & Research Centre Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Modern Diagnostic & Research Centre Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |